Supply unit
    4.
    发明授权
    Supply unit 失效
    供应单位

    公开(公告)号:US5895886A

    公开(公告)日:1999-04-20

    申请号:US604863

    申请日:1996-02-22

    CPC classification number: A61G12/005 H02G3/0431

    Abstract: A supply unit for supplying a workplace with electricity and/or gaseous media, with a first, vertically extending supply duct and a second, vertically extending supply duct, wherein the electricity and the media are led to connections on at least one of the supply ducts. From these connections the workplace is supplied and improved such that the ergonomically most favorable arrangement of the supply tubes and electric lines leading to the connections will be possible. This object is accomplished by a section of the side surfaces having an angle of inclination less than 90.degree. in relation to the base such that the ends of the side surfaces pointing away from the base can be connected at a common junction. The connections are arranged exclusively on the outer side surfaces and that the distance between the supply ducts is such that the workplace can be brought into the space between the supply ducts.

    Abstract translation: 用于向工作场所提供电和/或气体介质的供应单元,具有第一垂直延伸的供应管道和第二垂直延伸的供应管道,其中电力和介质被引导到至少一个供应管道 。 通过这些连接,工作场所被提供和改进,使得通向连接的供应管和电线的人机工程学上最有利的布置将是可能的。 该目的是通过侧面的一部分相对于基部具有小于90度的倾斜角来实现的,使得指向远离基部的侧表面的端部可以在公共接合处连接。 连接仅排列在外侧表面上,并且供应管道之间的距离使得工作场所能够进入供应管道之间的空间。

    Inhibitors of nucleoside phosphorylases and nucleosidases
    8.
    发明申请
    Inhibitors of nucleoside phosphorylases and nucleosidases 有权
    核苷磷酸酶和核苷酸的抑制剂

    公开(公告)号:US20060160765A1

    公开(公告)日:2006-07-20

    申请号:US10524995

    申请日:2003-08-21

    CPC classification number: C07D473/30 C07D473/34 C07H19/23

    Abstract: The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.

    Abstract translation: 本发明涉及作为嘌呤粘蛋白磷酸化酶(PNP),嘌呤磷酸核糖基转移酶(PPRT),5'-甲硫基腺苷磷酸化酶(MTAP),5'-甲硫基腺苷粘蛋白酶(MTAN)和/或 核苷水解酶(NH)。 本发明还涉及这些化合物在治疗包括癌症,细菌感染,原生动物感染和T细胞介导的疾病的疾病和感染中的用途以及含有该化合物的药物组合物。

Patent Agency Ranking